Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03747614Phase 4Unknown
Phase 4, open-label trial (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoints: Conjunctival microvascular blood flow velocity at 60 days, Conjunctival microvascular diameter at 60 days and 2 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03747614.